Amgen and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved TEZSPIRE® (tezepelumab-ekko) for the add-on maintenance treatment of inadequately controlled chronic ...
Following the inauguration of Donald Trump in January 2017, we witnessed a sustained, years-long effort to erase protections for LGBTQ people across the entire federal government. This included an all ...
Victims of AT&T data breaches can claim up to $7,500 if they file a claim by the deadline. Peter is a writer and editor for the CNET How-To team. He has been covering technology, software, finance, ...
Three data center projects did not follow through on the economic promises they made to Virginia, according to an unreleased ...
In the real world, we call it FOMO. The fear of missing out on big gains that others have reaped. And because most people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback